Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension

Figure 3.
Figure 3. Cough as an adverse event: angiotensin-converting enzyme (ACE) inhibitors versus angiotensin II receptor blockers (ARBs).

The first group is observational studies and the second group is randomized, controlled trials.

This Article

  1. Published online before print November 5, 2007, Ann Intern Med January 1, 2008 vol. 148 no. 1 16-29
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)
  5. Audio Summary

Current Issue

  1. November 17, 2009, 151 (10)
  1. Alert me to current issues